| Efficacy, Safety and Exploratory Clinical Study of Bevacizumab Combined With Oxaliplatin and TAS-102 in First-line Treatment of Advanced Colorectal Cancer (NCT05364489) | The First Affiliated Hospital of Zhengzhou University | 2022-06-15 |
| A Prospective Cohort Study of Advanced Colorectal Cancer Treated With Oxaliplatin and Irinotecan. (NCT05731336) | Sun Yat-sen University | 2022-05-01 |
| JAB-21822 in Combination With Cetuximab in Patients With Advanced CRC and Other Solid Tumors With KRAS G12C Mutation (NCT05194995) | Allist Pharmaceuticals, Inc. | 2022-02-17 |
| Surufatinib Combined With Sintilimab for Advanced MSS-Type Colorectal Cancer : a Phase II Study (NCT04764006) | Fujian Cancer Hospital | 2021-10-13 |
| IMC001 for Clinical Research on Advanced Digestive System Malignancies (NCT05028933) | Zhejiang University | 2021-09-30 |
| Trifluridine/Tipiracil Combined With Oxaliplatin and Bevacizumab Versus XELOX Plus Bevacizumab in mCRC (NCT05077839) | Tianjin Medical University Cancer Institute and Hospital | 2021-09-01 |
| FOLICOLOR TRIAL: Following Therapy Response Through Liquid Biopsy in Metatstatic Colorectal Cancer Patients (NCT07558083) | University Hospital, Antwerp | 2021-08-16 |
| Anlotinib Combined With mXELIRI as Second-line Treatment of Advanced Colorectal Cancer (NCT05035914) | Guangzhou University of Traditional Chinese Medicine | 2021-07-09 |
| Phase 3 Study of MRTX849 With Cetuximab vs Chemotherapy in Patients With Advanced Colorectal Cancer With KRAS G12C Mutation (KRYSTAL-10) (NCT04793958) | Mirati Therapeutics Inc. | 2021-06-24 |
| Surufatinib Combine With Immunotherapy and Chemotherapy for Second-line Treatment in Advanced Colorectal Cancer (NCT04929652) | Jiangsu Cancer Institute & Hospital | 2021-06-01 |
| Second-line Surufatinib Combined With Chemotherapy in Advanced CRC (NCT04734249) | Fujian Cancer Hospital | 2021-03-01 |
| Regorafenib Treatment Patterns and Survival Outcomes in Advanced Colorectal Cancer: A Real-world Study (NCT04835324) | Chinese Academy of Medical Sciences | 2020-10-01 |
| A Study of AL2846 Capsule Combined With Standard Chemotherapy Regimen in Subjects With Advanced Colorectal Cancer (NCT04337879) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2020-07-20 |
| A Study of Bevacizumab Plus XELOX/XELIRI for First-line Treatment in Unresectable Advanced Colorectal Cancer (NCT04324476) | Jiangsu Cancer Institute & Hospital | 2019-09-01 |
| Identification of New Patient Stratification Tools in MSS RAS mt mCRC (NCT03699111) | Cancer Trials Ireland | 2018-09-19 |
| Folfiri/aflIbercept in Metastatic coloreCTal Cancer patIents With RAS Validated Wild typE Status (NCT04252456) | Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente | 2018-04-23 |
| Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Colorectal Cancer (NCT03524274) | Fuda Cancer Hospital, Guangzhou | 2018-04-05 |
| Anti-EGFR Therapy Rechallenge in Combination With Chemotherapy in Patients With Advanced Colorectal Cancer (NCT03311750) | Hellenic Cooperative Oncology Group | 2018-03-26 |
| Clinical Trial of PM60184 in Advanced Colorectal Cancer After Standard Treatment (NCT03427268) | PharmaMar | 2018-01-16 |
| Raltitrexed-based Chemotherapy Plus Bevacizumab in Retreated Patients With Advanced Colorectal Cancer (NCT03126071) | Jiangsu Cancer Institute & Hospital | 2017-02-15 |
| Efficacy and Safety Evaluation of Traditional Chinese Medicine in the Treatment of Advanced Colorectal Cancer (NCT02923622) | Xiyuan Hospital of China Academy of Chinese Medical Sciences | 2016-09-01 |
| Regorafenib Monotherapy as Second-line Treatment of Patients With RAS-mutant Advanced Colorectal Cancer (NCT02619435) | National Cancer Institute, Naples | 2015-11-01 |
| Evaluate the Efficacy of MEDI4736 in Immunological Subsets of Advanced Colorectal Cancer (NCT02227667) | Memorial Sloan Kettering Cancer Center | 2014-12-02 |
| A First-in-man Phase I/II Study of Oral ONC201 in Patients With Advanced Cancer (NCT02038699) | Jazz Pharmaceuticals | 2014-01-01 |
| Effect of Curcumin on Dose Limiting Toxicity and Pharmacokinetics of Irinotecan in Patients With Solid Tumors (NCT01859858) | UNC Lineberger Comprehensive Cancer Center | 2013-06-01 |
| ANGIOPREDICT. ICORG 12-16, V3 (NCT01822444) | Cancer Trials Ireland | 2012-11-01 |
| A Phase II Trial of Salvage Treatment With Gemcitabine and S-1 Combination in Patients With Heavily Treated Advanced Colorectal Cancer. (NCT01929421) | Gachon University Gil Medical Center | 2009-12-01 |
| Study of Nimotuzumab to Treat Colorectal Cancer (NCT00972465) | Peking University | 2009-06-01 |
| Methotrexate in Metastatic Colorectal Cancer With MSH2 Deficiency (NCT00952016) | Royal Marsden NHS Foundation Trust | 2009-02-01 |
| Oxaliplatin, Capecitabine and Endostar as First Line Treatment for Patients With Advanced Colorectal Cancer (NCT00853684) | Shanghai Jiao Tong University School of Medicine | 2009-02-01 |
| Efficacy Study of TKcell in Advanced Colorectal Cancer (NCT00854971) | Binex | 2009-01-01 |
| Phase 2 Study of ABT-869 in Combination With mFOLFOX6 Versus Bevacizumab in Combination With mFOLFOX6 to Treat Advanced Colorectal Cancer (NCT00707889) | AbbVie (prior sponsor, Abbott) | 2008-10-01 |
| Efficacy Analysis of Cetuximab Plus Irinotecan in Patients With Wild-type KRAS Without Regard to Epidermal Growth Factor Receptor (EGFR) Expressions (NCT00637091) | Asan Medical Center | 2008-03-01 |
| A Pilot Study of PPX in Women With Metastatic Colorectal Cancer (NCT00598247) | University of Southern California | 2008-01-01 |
| Glivec® Plus m-FOLFOX Avastin® in Advanced Colorectal Cancer (NCT01271166) | Novartis Pharmaceuticals | 2007-10-01 |
| A Phase II Study of the Safety and Efficacy of E7820 Plus Cetuximab in Colorectal Cancer, Preceded by a Run-in Study in Advanced Solid Tumors (NCT00309179) | Eisai Inc. | 2007-09-24 |
| A Phase II Study of CP-4055 as Second Line Therapy in Patients With Advanced Colorectal Cancer (NCT00498407) | Clavis Pharma | 2007-05-01 |
| Chemoradiation for Locally Advanced and Low Rectal Cancers: Avastin-Capecitabine-Oxaliplatin-Radiation REctal Cancer Trial (NCT00386828) | British Columbia Cancer Agency | 2006-10-01 |
| High Dose Simplified Folfiri in Advanced Colorectal Cancer: a Multicentre Phase II Study (NCT00286000) | University Hospital, Ghent | 2004-06-01 |
| Sequential Versus Combination Chemotherapy in Advanced Colorectal Carcinoma (NCT00312000) | Dutch Colorectal Cancer Group | 2003-01-01 |